Detalles de la búsqueda
1.
IKZF1plus is a frequent biomarker of adverse prognosis in Mexican pediatric patients with B-acute lymphoblastic leukemia.
Front Oncol
; 14: 1337954, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38634053
2.
Implementation of a roadmap for the comprehensive diagnosis, follow-up, and research of childhood leukemias in vulnerable regions of Mexico: results from the PRONAII Strategy.
Front Oncol
; 14: 1304690, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38634051
3.
Epidemiology of childhood acute leukemias in marginalized populations of the central-south region of Mexico: results from a population-based registry.
Front Oncol
; 14: 1304263, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38444682
4.
Subclassification of B-acute lymphoblastic leukemia according to age, immunophenotype and microenvironment, predicts MRD risk in Mexican children from vulnerable regions.
Front Oncol
; 13: 1304662, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38250553
Resultados
1 -
4
de 4
1
Próxima >
>>